QualityStocksNewsBreaks Archives - Page 582 of 1422

FridayAug 27, 2021 1:02 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology Is ‘Outrageously Fast’ in Oral to Bloodstream Delivery

Lexaria Bioscience Corp. (NASDAQ: LEXX) on July 22 announced it had met three primary objectives in its investigation of antiviral drug conversion process outcomes as the drugs are processed with its patented DehydraTECH(TM). “The success achieved during the company’s testing paves the way for larger analysis of the DehydraTECH-processed drugs in vivo in animals infected with SARS-CoV-2/COVID-19, HIV/AIDS, or other infectious disease-causing viruses, according to the company. The ultimate aim is to form partnerships with established pharmaceutical industry drug-makers who may be interested in incorporating DehydraTECH technology with those tested drugs, or other drugs with similar characteristics,” reads a recent…

FridayAug 27, 2021 11:37 am

QualityStocksNewsBreaks – Trident Acquisitions Corp. (NASDAQ: TDAC) Files Updated Investor Presentation for Business Combination with Lottery.com

Trident (NASDAQ: TDAC, TDACU, TDACW), a special purpose acquisition company, previously announced its entry into a definitive agreement with AutoLotto Inc. (doing business as “Lottery.com”), a leading platform to play the lottery online. The agreement allows Lottery.com to become a publicly listed company. Trident today announced that it has filed an updated investor presentation with the Securities and Exchange Commission (“SEC”) in connection with its business combination with Lottery.com. The presentation includes, among other things, positive updates to peer valuation metrics and reiterates Lottery.com’s strong financial outlook and 2021 financial projections. The outlook is supported by strong preliminary second quarter…

FridayAug 27, 2021 11:17 am

QualityStocksNewsBreaks – Grapefruit USA Inc. (GPFT) Committed to Creating High-Quality Products for Its Customers, Human or Otherwise

Grapefruit USA (OTCQB: GPFT) understands that humans aren’t the only ones who may benefit from all that cannabidiol (“CBD”) has to offer and is positioning in a rapidly growing market. The pet CBD industry has experienced significant growth over the last several years, with the Brightfield Group projecting an expected market valuation of more than $1.7 billion by 2025 (https://ibn.fm/p4rDv). Grapefruit is leveraging its expertise in the space with the launch of a new USDA-certified organic CBD pet tincture. “We understand that pet owners are now demanding organic, plant-based, natural remedies to keep their furry family members calm and in…

FridayAug 27, 2021 11:02 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Eyes Fueled Mission to Develop Revolutionary Psychedelic Therapeutics

Cybin (NEO: CYBN) (NYSE American: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, in a recent historic move became the first psychedelic biotech company to trade on the NYSE American LLC stock exchange. “We are all delighted to receive this approval from the NYSE American and are thankful to our wonderful team and loyal investor base who have followed us on this journey so far,” an article quoted Cybin CEO Doug Drysdale discussing the milestone. “As the first psychedelic biotech company that will now trade on this esteemed exchange in the U.S., we will…

FridayAug 27, 2021 10:43 am

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Modernizing, Increasing Accessibility to Brain Diagnostics

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, is fulfilling its mission of modernizing and increasing accessibility to brain diagnostics with its FDA-cleared NeuroCap(TM) and NeuroEEG(TM), which are already patented in the United States, China and Europe. As the company’s first commercialized devices, they are designed to disrupt the current electroencephalogram (“EEG”) market by offering a cost-effective and disposable alternative to existing solutions. A recent article reads, “Brain Scientific’s development process spans three stages. The first development phase, from 2018 to 2019, resulted in the inception of the company’s portable, clinical-grade, easy-to-use neurological devices.…

FridayAug 27, 2021 10:23 am

QualityStocksNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Closes on $3M Convertible Note

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company focused on advancing new methods of visualizing cancer during minimally invasive procedures, announced that it had secured a new convertible note totaling $3 million. Financing for the note, which was comprised of three tranches, was led by Rapha Capital BioVentures Fund I, LP (“RCBVFI”). The company anticipates using the funds to support the clinical development of its lead product, the i/Blue(TM) Imaging System. According to the company, the proprietary system is poised to increase patient access to this important technology. In addition to the funding, Imagin Medical also named Kevin…

FridayAug 27, 2021 10:05 am

QualityStocksNewsBreaks – Sustainable Green Team Ltd. (SGTM) Offering Efficient Solutions Before and After Storms

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, and its portfolio of subsidiaries specialized in tree services, debris hauling, biomass recycling, and manufacture of next-generation mulch products and cypress lumber, have the necessary expertise to deal with storms and their negative impact. According to a recent article, SGTM’s vertically integrated operations include three brands “that speak quite clearly to the corporate mission to reduce environmental impact through responsible handling of tree debris rather than burying it in already over-burdened landfills.” The process is efficient and green. “From a mobile command…

FridayAug 27, 2021 9:38 am

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Featured in Equity Research Report

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, was featured in a recent equity research report. The coverage, initiated by Ladenburg Thalmann & Co. Inc., highlights Tryp Therapeutics’ efforts to reset the treatment of various disorders through the novel dosing of formulations of synthetic psilocybin. “We are initiating coverage on Tryp Therapeutics with a Buy rating and $2.00 price target based on our research into its psychedelic-based pipeline, which is leveraging psilocybin’s potential to treat patients with inadequately addressed neurological disorders. The company is on track to test…

ThursdayAug 26, 2021 2:17 pm

QualityStocksNewsBreaks – Why Streamlytics Is ‘One to Watch’

Streamlytics is focused on providing ethical, people-powered data, spanning millions of data points from today’s fastest growing communities across the United States. Through partnering with consumers nationwide, the company has gained unparalleled access to audiences’ and shoppers’ purchasing patterns and content consumption across Netflix, Google, Amazon and others. “Since its founding, the company’s mission has been to disrupt the deceptive online data collection processes that have become commonplace. Streamlytics’ drive to prioritize consumer data collection transparency and ethics has led to tremendous growth. The company recently announced it had reached a milestone of more than a quarter-billion data points. Streamlytics’…

ThursdayAug 26, 2021 2:07 pm

QualityStocksNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Launches Media Blitz Amid Sweeping Executive Order

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, recently launched a six-month national “Media Blitz” campaign aimed at an estimated 48 million Americans currently suffering from hearing loss (https://ibn.fm/kdCpp). This move was on the heels of President Biden’s signing of a sweeping executive order in early July, aimed at promoting “greater competition in the American economy,” that directs the U.S. Department of Health and Human Services “to consider issuing proposed rules within 120 days for allowing hearing aids to be sold over the counter” (https://ibn.fm/oG58N). “InnerScope Hearing Technologies is favorably positioned…

Site Search

Company Search

Category: QualityStocksNewsBreaks